2022 year in review
Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.
The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.
The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.